Patients sue GLP-1 makers over sudden loss of vision

Дата публикации: 22-09-2026 11:43:10

Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	GLP-1-driven vitamin deficiency linked to rare brain disorder: Study	0	10.4	12-09-2026
2	أدوية إنقاص الوزن تواجه دعاوى بسبب حالة نادرة بالعين	0	6.73	25-09-2026
3	Abnehmspritzen und Sehverlust: Hunderte Amerikaner verklagen Novo Nordisk und Eli Lilly	0	11.02	22-09-2026
4	Sponsored Content: A Possible Alternative to GLP-1 Treatments	0	6.5	16-09-2026
5	STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’	0	7.79	28-09-2026
6	Descartan que usar Ozempic influya en el riesgo de enfermedad ocular degenerativa	0	7.65	17-08-2026
7	Millions more people with overweight could benefit from GLP-1 drugs to protect heart health, study suggests	0	7.86	27-09-2026
8	STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more	0	6.55	28-09-2026
9	Largo man sues Publix after wife dies from contaminated blueberries: documents	0	7.35	23-09-2026
10	GLP-1 Drugs Not the Most Effective Treatment for Obstructive Sleep Apnea	0	9.78	25-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.29. Источник: www.ksn.com.